Marianne de Backer, Chief Executive Officer at Vir Biotechnology, Inc. (VIR), sold 145,990 shares at $9.46 ($1.4M) on 2024-04-03, disclosed to the SEC on 2024-04-04.
Scheduled sale ($1.4M) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.46 | 72,995 | $691K | 50.0% |
| 2 | $9.46 | 72,995 | $691K | 50.0% |
| Total | $9.46 avg | 145,990 | $1.4M | 100% |
| Filing → |
| VIR | SELL | 2026-02-24 | $284K | — | Filing → |
| VIR | SELL | 2025-04-04 | $949K | — | Filing → |
| VIR | SELL | 2025-02-25 | $305K | — | Filing → |